Edesa Biotech, Inc. (EDSA)

Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year	Current	2023	2022	2021	2020	2018
Market Capitalization	14	13	14	98	76	5
Market Cap Growth	-27.33%	-6.42%	-85.44%	28.76%	1466.15%	-59.36%
Enterprise Value	11	8	7	90	69	1
PE Ratio	-	-1.59	-0.81	-7.33	-11.94	-2.60
PS Ratio	-	-	-	-	231.06	-
PB Ratio	3.13	1.89	1.52	7.49	11.46	1.51
P/FCF Ratio	-2.10	-2.01	-1.16	-7.16	-15.39	-3.74
P/OCF Ratio	-2.10	-2.01	-1.16	-7.16	-15.24	-3.76
EV/Sales Ratio	-	-	-	-	209.62	-
EV/EBITDA Ratio	-1.50	-0.98	-0.41	-6.81	-10.93	-0.80
EV/EBIT Ratio	-1.46	-0.96	-0.41	-6.75	-10.83	-0.80
EV/FCF Ratio	-1.66	-1.22	-0.58	-6.59	-13.96	-1.15
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.02	-
Debt / EBITDA Ratio	-0.01	-0.01	0.00	-0.01	-0.03	-
Debt / FCF Ratio	-0.01	-0.01	0.00	-0.01	-0.03	-
Quick Ratio	1.82	3.29	3.90	7.64	4.77	18.36
Current Ratio	1.97	3.53	4.25	8.29	5.30	18.45
Asset Turnover	0	0	0	0	0.04	0
Return on Equity (ROE)	-115.60%	-98.00%	-143.80%	-95.30%	-110.00%	-23.60%
Return on Assets (ROA)	-88.90%	-82.40%	-113.50%	-81.20%	-78.60%	-22.40%
Return on Capital (ROIC)	-194.22%	-129.11%	-195.22%	-179.98%	-94.19%	-50.35%
Earnings Yield	-53.51%	-62.82%	-123.19%	-13.64%	-8.38%	-38.45%
FCF Yield	-46.83%	-49.78%	-86.24%	-13.97%	-6.50%	-26.71%
Buyback Yield / Dilution	-11.89%	-36.37%	-21.50%	-40.32%	-165.66%	-1229.24%
Total Shareholder Return	-11.89%	-36.37%	-21.50%	-40.32%	-165.66%	-1229.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).